Literature DB >> 8319244

Biological significance of autologous tumor-killing activity and its induction therapy.

A Uchida1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8319244     DOI： 10.1007/bf01517038

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN： 0340-7004            Impact factor:   6.968


× No keyword cloud information.
  50 in total

1.  Characterization of human autotumor-reactive T-cell clones obtained from tumor-infiltrating lymphocytes in liver metastasis of gastric carcinoma.

Authors:  Y Shimizu; E Weidmann; S Iwatsuki; R B Herberman; T L Whiteside
Journal:  Cancer Res       Date:  1991-11-15       Impact factor: 12.701

2.  Lysis of autologous tumor cells by high-density lymphocytes is potentiated by the streptococcal preparation OK432 (Picibanil).

Authors:  F Vánky; A Uchida; E Klein; J Willems
Journal:  Int J Cancer       Date:  1986-04-15       Impact factor: 7.396

Review 3.  Cellular immune response against autologous human malignant melanoma: are in vitro studies providing a framework for a more effective immunotherapy?

Authors:  G Parmiani; A Anichini; G Fossati
Journal:  J Natl Cancer Inst       Date:  1990-03-07       Impact factor: 13.506

4.  Correlation between lymphocyte-mediated auto-tumor reactivities and clinical course. I. Evaluation of 46 patients with sarcoma.

Authors:  F Vánky; J Willems; A Kreicbergs; T Aparisi; M Andréen; L A Broström; U Nilsonne; E Klein; G Klein
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

5.  Natural killer cell activity and head and neck cancer: a clinical assessment.

Authors:  S P Schantz; E J Shillitoe; B Brown; B Campbell
Journal:  J Natl Cancer Inst       Date:  1986-10       Impact factor: 13.506

6.  Correlation between long-term survival in breast cancer patients and amplification of two putative oncogene-coamplification units: hst-1/int-2 and c-erbB-2/ear-1.

Authors:  H Tsuda; S Hirohashi; Y Shimosato; T Hirota; S Tsugane; H Yamamoto; N Miyajima; K Toyoshima; T Yamamoto; J Yokota
Journal:  Cancer Res       Date:  1989-06-01       Impact factor: 12.701

7.  Role of MHC class-I antigens and the CD3 complex in the lysis of autologous human tumours by T-cell clones.

Authors:  T E Roberts; U Shipton; M Moore
Journal:  Int J Cancer       Date:  1987-04-15       Impact factor: 7.396

8.  Tumor-derived interleukin-2-dependent lymphocytes in adoptive immunotherapy of lung cancer.

Authors:  R L Kradin; L A Boyle; F I Preffer; R J Callahan; M Barlai-Kovach; H W Strauss; S Dubinett; J T Kurnick
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

9.  Specific and non-specific lymphocyte cytotoxicity in colon carcinoma.

Authors:  B M Vose; P Gallagher; M Moore; P F Schofield
Journal:  Br J Cancer       Date:  1981-12       Impact factor: 7.640

10.  Lysis of fresh human tumor cells by autologous peripheral blood lymphocytes and tumor-infiltrating lymphocytes activated by PSK.

Authors:  Y Kariya; N Okamoto; T Fujimoto; N Inoue; T Kihara; K Sugie; M Yagita; H Kanzaki; T Mori; A Uchida
Journal:  Jpn J Cancer Res       Date:  1991-09
View more
  1 in total

1.  Non-fastidious, melanoma-specific CD8+ cytotoxic T lymphocytes from choroidal melanoma patients.

Authors:  X Q Huang; M S Mitchell; P E Liggett; A L Murphree; J Kan-Mitchell
Journal:  Cancer Immunol Immunother       Date:  1994-06       Impact factor: 6.968
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.